COPD
Feature
Climate change magnifies health effects of wildfire smoke in care deserts
About 5.5 million Americans live in the 488 counties where drive times to pulmonologists are an hour or more.
Conference Coverage
Lung volume reduction methods show similar results for emphysema
“Until now there had been no direct comparison of the two to inform decision-making.”
Conference Coverage
Biomarker-guided steroid therapy shown safe for COPD
“A personalized endotype-based treatment with oral prednisolone is possible in patients with COPD.”
Conference Coverage
RETHINC takes air out of COPD-like therapy for smokers
Bronchodilator therapy was no better than placebo at reducing respiratory symptoms in smokers without airway obstruction.
From the Journals
Sclerostin predicts exacerbations in COPD patients
Sclerostin is associated with bone metabolism and may play a role in “muscle-bone crosstalk.”
From the Journals
Home program improves some functional capacity in COPD
“Home-based programs became increasingly popular in the last years and complement traditional center-based inpatient and outpatient PR.”
From the Journals
Screen COPD patients for peripheral neuropathy
Polyneuropathy remains a common comorbidity among patients with chronic obstructive pulmonary disease.
From the Journals
Airway structure in women leads to worse COPD outcomes
Worse COPD outcomes found for women for each unit change in wall thickness or lumen area.
Perspectives
Exercise limitations in COPD – not everyone needs more inhalers
Only one of three major COPD abnormalities responds to inhalers.
Feature
Trials data on COPD leave primary care docs in the dark
The kinds of patients in primary care may not completely mimic those in clinical trials.